Maxresorb is a 100% synthetic and safe bone graft with a very similar composition to human bone (60% HA, 40% β-TCP). It provides controlled stability and resorption, with interconnecting pores that favour osteoconductivity.
Calcium phosphate product
Calcium phosphate is characterised by its excellent biocompatibility and the absence of adverse reactions in the body. It also has bioactive and resorption properties that allow natural bone remodelling. This process consists of an initial integration of the material into the surrounding bone matrix (rapid resorption of β-TCP as it is more soluble) followed by gradual degradation (resorption of HA in 1-2 years).
Biphasic and homogeneous composition in each particle
Maxresorb biphasic particles are composed of a hydroxyapatite (HA) nucleus surrounded by a layer of beta-tricalcium phosphate (β-TCP). The different solubility of these materials provides a combination of slow resorption of the graft and formation of new bone matrix. Studies have shown that the optimal HA:β-TCP ratio is between 65:35 and 55:45.
Controlled full resorption
The combination of HA and β-TCP in maxresorb provides the advantages of both materials in a final biomaterial that shows excellent osteoconductivity. The rapid resorption afforded by β-TCP provides a space for new bone formation. The low solubility of HA provides volume maintenance over a long period of time.
Maxresorb is a suitable alternative for patients who, for various reasons, such as ethical, social or religious reasons, do not accept grafting material of animal origin.
- Socket and ridge preservation.
- Periodontal regeneration of furcation defects (Class I and II).
- Horizontal and vertical or combined bone regeneration.
- Regeneration of peri-implant bone defects.
- Periodontal regeneration of infra-osseous defects.
- Maxillary sinus lift.
*Botiss biomaterials product distributed by Klockner S.A. in Spain and Portugal